Boston Partners
Institutional investor · Portfolio as of Q2 2020
Top Holdings653 positions
JPMORGAN CHASE & CO | 10.1M | $946.3M | 1.7% | $103.40 | -22.70% | 7 qtrssince 2018-Q4 | Increased 53 |
BERKSHIRE HATHAWAY INC DEL | 4.7M | $841.6M | 1.5% | $204.63 | -12.77% | 7 qtrssince 2018-Q4 | Decreased 0 |
JOHNSON & JOHNSON | 5.9M | $831.5M | 1.5% | $110.95 | +6.77% | 7 qtrssince 2018-Q4 | Decreased 0 |
CISCO SYS INC | 17.4M | $811M | 1.5% | $37.58 | +3.78% | 7 qtrssince 2018-Q4 | Increased 81 |
BANK OF AMER CORP | 33.5M | $794.7M | 1.5% | $20.82 | -1.80% | 7 qtrssince 2018-Q4 | Decreased 0 |
AUTOZONE INC | 683,684 | $771.4M | 1.4% | $973.75 | +15.85% | 6 qtrssince 2019-Q1 | Decreased 0 |
THE CIGNA GROUP | 4M | $756.7M | 1.4% | $172.95 | -2.40% | 7 qtrssince 2018-Q4 | Decreased 0 |
EATON CORP PLC | 8.3M | $724.6M | 1.3% | $68.61 | +14.57% | 7 qtrssince 2018-Q4 | Increased 50 |
PFIZER INC | 21.8M | $711.7M | 1.3% | $27.58 | -17.85% | 7 qtrssince 2018-Q4 | Decreased 0 |
ALPHABET INC | 456,054 | $647M | 1.2% | $62.51 | +12.35% | 7 qtrssince 2018-Q4 | Increased 62 |
ELEVANCE HEALTH INC FORMERLY | 2.3M | $611.5M | 1.1% | $234.63 | +2.55% | 7 qtrssince 2018-Q4 | Decreased 0 |
AMERICAN INTL GROUP INC | 19.2M | $598.4M | 1.1% | $30.66 | -12.67% | 7 qtrssince 2018-Q4 | Decreased 0 |
DUPONT DE NEMOURS INC | 11.1M | $589.7M | 1.1% | $74.22 | -19.83% | 5 qtrssince 2019-Q2 | Increased 53 |
NOVARTIS AG | 6.7M | $581M | 1.1% | $66.99 | +3.95% | 7 qtrssince 2018-Q4 | Increased 80 |
TRUIST FINL CORP | 15.4M | $576.4M | 1.1% | $40.58 | -30.43% | 3 qtrssince 2019-Q4 | Increased 53 |
QORVO INC | 5.1M | $560.3M | 1.0% | $89.79 | +19.64% | 7 qtrssince 2018-Q4 | Increased 54 |
CHUBB LIMITED | 4.3M | $542.9M | 1.0% | $127.95 | -9.40% | 7 qtrssince 2018-Q4 | Decreased 0 |
| 19.2M | $536M | 1.0% | — | — | — | — | |
MEDTRONIC PLC | 5.7M | $526.3M | 1.0% | $82.18 | -7.31% | 7 qtrssince 2018-Q4 | Decreased 0 |
NXP SEMICONDUCTORS N V | 4.6M | $525.7M | 1.0% | $98.78 | +3.86% | 6 qtrssince 2019-Q1 | Decreased 0 |
Boston Partners manages $54.4B across 653 positions as of Q2 2020. Top holdings: JPM (1.7%), BRK/B (1.5%), JNJ (1.5%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Active quarter - 96 new positions, 84 exits, 163 increased. Top move: CSCO (INCREASED, conviction 81). Portfolio: $54.4B across 653 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR